Clinical Study of Personalized Chemotherapy for Breast Cancer With Low Doses of Cyclophosphamide

Inclusion Criteria

• •stage IV breast cancer or progression of the disease with the presence of foci accessible for biopsy of tumor material;
• •complete awareness of the patient about the prognosis of the disease and the proposed treatment;
• •the volume of tumor material required for vital assessment of the time parameters of the individual reparative cycle of tumor cells must be at least 4 cm3;
• •tumor cells transferred to primary culture must be in a state of proliferative activity.